Has Apple Finally Claimed Its Seat at the AI Rally?

Technology

GSK Pays 40% Premium to Buy Nuvalent in Major Oncology Push

Life Science

Apple Announces AI Progress at WWDC, Partners with Google and Nvidia to Build Cloud-Based Models

Technology

Global LNG Frenzy: 4 High-Potential Stocks to Ride the Boom

Energy

Marvell Tapped for S&P 500: Can the AI Chip Rival Emerge as the Next Nvidia?

Technology

AI Selloff: Should Investors Buy the Dip or Shift to Value Stocks?

Financial Service, Technology

Should You Buy SpaceX Stock at Its IPO? 3 Pros and 2 Cons

Technology

After a 6% Drop, Nvidia Faces a Bigger Threat: Its Own Customers

Technology

These Two Canadian Dividend Stocks Balance Low Volatility with Long-Term Growth Potential

Energy

RVMD’s Near-100% Year-To-Date Rally Sparks Valuation Debate: Has the Stock Gotten Too Pricy?

Life Science

CrowdStrike Unveils 4-for-1 Stock Split After More Than 20x Share Surge Since IPO

Technology

Two Beaten-Down Pharma Giants: Biotech’s Cyclical Turn Delivers Prime Dip-Buy Opportunities

Life Science

Alphabet’s Growth Thesis Reshaped by Anthropic’s Looming IPO via TPU Supply and Equity Stakes

Technology

Moderna Outshines Pharma Giants Lilly, Merck and Pfizer With 43% Year-to-Date Surge

Life Science

Broadcom’s AI Revenue Surges 143% in Q2, Yet Shares Tumble Post-Earnings

Technology